Introduction {#sec1-1}
============

The etiologies of several exanthema including pityriasis rosea (PR), Gianotti-Crosti syndrome (GCS), asymmetric periflexural exanthem/unilateral laterothoracic exanthem (APE/ULE), papular-purpuric gloves and socks syndrome (PPGSS), eruptive pseudoangiomatosis (EP), and eruptive hypomelanosis (EH) are incompletely understood.

There are four ways to investigate such exanthema: clinical studies, laboratory-based studies, epidemiology studies, and, relatively indirect, clinical trials.

For clinical studies, a diagnostic criteria and a set of classification were postulated and validated.^[@ref1]^ For laboratory-based studies, we progressed from Koch's postulates (which did not take viral infections into account)^[@ref2]^ to Rivers' criteria (modified from Koch's postulates to cater for viral infections),^[@ref3]^ and then to other criteria such as those postulated by Fredericks and Relman^[@ref4]^ (which take DNA and mRNA sequence-detection procedures into account).^[@ref3]^ Virological tools such as real-time PCR, virus load, reverse-transcriptase PCR, and antibody avidities are much advanced today.

For clinical trials, studies on the use of macrolides and anti-viral medications in PR are escalating in number and in the qualities of the methodologies.^[@ref5]^ Patient-assessed parameters such as quality of care are being incorporated as outcome measures in the more recent studies,^[@ref6],[@ref7]^ in line with studies for other skin diseases.

Tools in epidemiology are now much advanced. Patient clustering and epidemics can now be detected by various analyses.^[@ref8],[@ref9]^ Softwares are available for systematic reviews and meta-analyses.^[@ref10]^ Various plots facilitate meta-analyses^[@ref11]^ and the estimation of publication bias.^[@ref12]^ We have postulated a protocol to establish and validate diagnostic criteria of skin diseases so that high homogeneities would be achieved in meta-analyses.^[@ref1]^ Platforms for dermato-epidemiology enable conjoint efforts to apply epidemiology methodologies to investigate patients and communities with skin diseases.^[@ref13]^

For epidemiological evidence for environmental causes, Hill's criteria (strength, consistency, specificity, temporality, biological gradient, plausibility, coherence, experimental evidence, and analogy)^[@ref14]^ is still applicable to some extent. For evaluating the evidence of efficacies of various treatment modalities, we have conducted a systematic review^[@ref15]^ and a Cochrane review^[@ref16]^ for PR, but not for other exanthema.

However, we lack a yardstick for the adequacies of epidemiological evidence in substantiating infectious etiologies. We therefore believe that a systemic and qualitative evaluation of the epidemiological evidence for infectious etiology of these exanthema is timely and necessitated.

Aim {#sec2-1}
---

Our aim was to conduct a systematic review on the epidemiology of PR, GCS, APE/ULE, PPGSS, EP, and EH, and to investigate whether the epidemiological findings substantiate infectious etiologies.

Materials and Methods {#sec1-2}
=====================

Literature search {#sec2-2}
-----------------

We searched for all articles published over the last 60 years and indexed in PubMed, placing more emphasis on epidemiology reports.

Analyses {#sec2-3}
--------

We analyzed the following epidemiological parameters: i) history and universality, ii) genetic makeup, iii) incidence and prevalence, iv) demography, v) concurrent patients, vi) patient clustering, vii) mini-epidemics and epidemics, and viii) other associations.

Some of these parameters are more important than others. History and universality by themselves are weak as evidence for an infectious etiology. Genetic makeup, unless widely reported with the genotypes identified and proven to be of close association with the phenotype, namely the skin rash, is also relatively weak evidence. Incidence and prevalence provide moderate levels of support.

Demography is important mainly due to the age of patients. If most patients are infants or children, it might be compatible with the hypothesis of lack of specific immunity upon the first exposure to the virus concerned. The absence or near-absence of relapse is highly characteristic of some viral infections. The demonstration of epidemics is a very strong substantiating factor for an infectious etiology, followed by the discovery of mini-epidemics, the reports of significant patient clustering, and then the depiction of concurrent patients.

As mentioned above, there is no threshold for the adequacy of epidemiology data in supporting infectious etiologies. We shall adopt a qualitative approach in our analyses.

Results {#sec1-3}
=======

For PR, we selected 55 articles;^[@ref17]^ 19 are epidemiology studies (summarized in [Table 1](#table001){ref-type="table"}).^[@ref18]^ One paper was not specific for PR.^[@ref29]^ We contacted the chief investigator (Nanda A, personal communication), and the data specific for PR became available. For GCS, APE/ULE, PPGSS, EP, and EH, we retrieved 60,^[@ref72]^ 29,^[@ref132]^ 36,^[@ref161]^ 20,^[@ref197]^ and four^[@ref217]^ articles respectively. The results of our analyses are summarized in [Table 2](#table002){ref-type="table"}.

Pityriasis rosea {#sec1-4}
================

PR is the commonest paraviral exanthema. After a prodromal coryzal phase, a herald patch ([Figure 1](#fig001){ref-type="fig"}) develops in around 30-50% of all patients. The generalized secondary eruption appear one to three weeks later, most commonly affecting the trunk and proximal aspects of limbs. Peripheral collarette scaling is seen in the herald patch and the larger lesions. The oval-shaped lesions might orient along lines of skin cleavage. Spontaneous remission is then seen in four to eight weeks for most patients.

History and universality {#sec2-4}
------------------------

PR was initially described by Camille Melchoir Gibert in 1860 in France.^[@ref17]^ The annular configuration was first described by Pierre-Antoine-Ernest Bazin in 1862, and the herald patch was first described in 1887.^[@ref17]^

Rashes with infectious etiologies would appear in various countries and regions, unless specific factors, like herd immunity, limit the susceptibility.

PR is universal.^[@ref17]^ The universality of PR shows that genetic predisposition is unlikely to be important. External factors are necessary. These factors are unlikely to be environmental, as people around the globe do not share similar environmental factors. A factor being an infectious microbe could explain the universality. We therefore believe that the universality of PR offers some support for an infectious etiology.

Genetic makeup {#sec2-5}
--------------

Brazilian black people with the alleles DQB1\*04 are more susceptible to develop PR (RR: 4.00; 95%CI: 1.2-13.28).^[@ref37]^ However, PR occurs in ethnicities without this alleles. Genetic makeup is thus unlikely to be important.

Incidence {#sec2-6}
---------

We performed quantitative analyses on the data of 2,888 patients with PR out of 454,254 dermatological patients in ten studies.^[@ref19],[@ref20],[@ref23],[@ref28],[@ref30],[@ref32],[@ref33]^ The overall incidence is 0.64 per 100 dermatological patients. On its own, incidence offers little substantiation for an infectious etiology.

Correlation with economic status {#sec2-7}
--------------------------------

We evaluated the correlation between the incidence and gross domestic product per capita for six countries (Uganda,^[@ref19]^ Nigeria,^[@ref20]^ Brazil,^[@ref23]^ Sudan,^[@ref24]^ Kuwait,^[@ref29]^ and India^[@ref33]^) with incidences of PR being accessible. Spearman rank-order correlation coefficient (γ~s~) was --0.0857 (insignificant). Economical status is thus not associated with the occurrence of PR.

Age {#sec2-8}
---

PR occurs in all ages from infants^[@ref39]^ to the elderlies,^[@ref41]^ with most patients between ten to 35 years of age.^[@ref40]^ We postulate that some patients with PR are due to primary viral infections, while others being related to endogenous reactivation.

From results of our previous PCR and serology studies,^[@ref41]^ we did find virological profiles compatible with primary infection in the younger patients, and profiles indicating endogenous reactivation of viruses in older patients. However, the distribution was statistically insignificant.

We thus believe that age offers some support for PR being related to infectious causes.

Sex {#sec2-9}
---

We analyzed 3809 patients with PR from 18 studies.^[@ref18]^ 1931 were males and 2630 were females (male: female ratio being 1:1.39). The female predominance may be related to altered immunomodulations during stress, such as pregnancy^[@ref45]^ or females seeking medical help more frequently.^[@ref46]^ Sex distribution offers no substantiation for an infectious etiology.

Low rate of relapse {#sec2-10}
-------------------

The rate of relapse of PR is 1.8-3.7%.^[@ref22],[@ref47],[@ref48]^ The herald patch was always absent in relapses.^[@ref48]^ A low rate of relapse is an epidemiological hallmark of viral infections.

Concurrent patients {#sec2-11}
-------------------

Reports of concurrent patients in close contact offer some support for an infectious etiology.^[@ref49]^

Patient clustering {#sec2-12}
------------------

Significant spatial-temporal clustering was reported for female patients.^[@ref27]^ However, the *moving window test* employed in that study was not a validated tool, and controls were unavailable.^[@ref160]^

We have applied a validated regression analysis with bootstrapped simulations, and reported a multi-center epidemiology study in primary care settings in Hong Kong (P=0.031).^[@ref60]^ We then applied the regression analysis to the epidemiology data of 1379 patients with PR in Kuwait, Turkey, and US.^[@ref61]^ Significant temporal clustering was found in all three patient series, while not found in control series of patients consulting for psoriasis).

Epidemics {#sec2-13}
---------

Mini-epidemics have been reported for PR.^[@ref53],[@ref55]^ Patient clustering and mini-epidemics thus support an infectious etiology. The strength of this support might be surpassed by the report of one major epidemic in the future, which would still be further surpassed by the report of multiple epidemics of similar natures.

Association with respiratory tract infections {#sec2-14}
---------------------------------------------

PR is associated with respiratory tract infections,^[@ref56]^ suggesting a droplet-spread microorganism being the cause.

Seasonal variation, weather and climate changes {#sec2-15}
-----------------------------------------------

Studies on seasonal variation^[@ref18],[@ref27],[@ref28],[@ref30],[@ref33]^ reported conflicting results ([Table 1](#table001){ref-type="table"}). Moreover, seasonal variation occurs in non-infectious diseases.^[@ref57]^

We have reported that PR is insignificantly associated with monthly mean air temperature (γ~s~=--0.41; P=0.19), monthly mean total rainfall (γ~s~=--0.34; P=0.27), and monthly mean relative humidity (γ~s~=--0.038; P=0.91).^[@ref54]^ Seasonal variations, weather and climate changes therefore do not support infectious etiologies.

Seroprevalence {#sec2-16}
--------------

Many studies substantiate the association of primary infection and endogenous reactivation of human herpes virus (HHV)-7 and -6 and PR.^[@ref58]^ For reasons yet unknown, negative findings were reported by us^[@ref41],[@ref42]^ and by several other investigators.^[@ref64]^ We have excluded the roles of three other herpes viruses \[HHV-8,^[@ref43]^ cytomegalovirus (CMV),^[@ref44]^ and Epstein-Barr virus (EBV)^[@ref44]^\] and parvovirus B19 (B19V)^[@ref44]^ in PR. Virological, immunohistochemical, and serological findings are not the realms in this review, but seroprevalence is. Previously, the gold criteria for primary infection of herpes viruses was seroconversion.^[@ref68]^ High virus load in the plasma or peripheral blood mononuclear cells together with IgG negativity would be contenders.^[@ref68],[@ref69]^ However, the background seroprevalences against different herpes viruses are different across the world.

Moreover, HHV-6 demonstrates chromosomal integration,^[@ref70]^ rendering interpretation of epidemiology data difficult. Seroprevalence might thus be a confounding independent variable in epidemiological analyses.^[@ref71]^

Analyses {#sec2-17}
--------

PR exhibits virtually absolute universality. The predominant age being 10-35 years might be due to viral primary infection for some patients and endogenous reactivation for others. Concurrent patients and patient clustering are well proven. We thus believe that the epidemiological evidence strongly substantiates PR being caused by infectious agents.

Gianotti-Crosti syndrome {#sec1-5}
========================

History and the initial clusters of children {#sec2-18}
--------------------------------------------

In 1952, Gianotti discovered groups of children in Milan with a monomorphous papular eruption mainly affecting extensor aspects of the extremities.^[@ref72]^ Fever, lymphadenitis, and hepatomegaly were sometimes seen. Gianotti suspected an infectious etiology owing to *monocytoid cells* and *Türk's cells* in the peripheral blood.

Age {#sec2-19}
---

Most patients with GCS are below the age of four,^[@ref76]^ compatible with primary infections of viruses. Adult patients are uncommon but not rare ([Figure 2](#fig002){ref-type="fig"}).

Sex {#sec2-20}
---

There was no sexual preponderance.^[@ref76]^ This is compatible with infectious disease, as sexual imbalance is seen in some genetic or congenital diseases.^[@ref71]^ However, for adults with GCS, a marginal predominance of females is seen,^[@ref71],[@ref76]^ the reason of which being yet unknown.

Initial laboratory evidence {#sec2-21}
---------------------------

Hepatitis B virus (HBV) surface antigen was found in the sera of children with GCS in 1970,^[@ref80],[@ref81]^ and HBV infection was assumed to be the sole culprit.

Patient clustering {#sec2-22}
------------------

Employing regression analyses with bootstrapped simulations, we have previously reported on the detection of spatial-temporal clustering for children with GCS (P=0.044).^[@ref82]^ We traced and found a 15-month-old boy with GCS eruption five days before attending a wedding party. Five other children attended the party, with three developing GCS five, eight and nine days after the party.

Epidemics {#sec2-23}
---------

Five epidemics have been reported, the first three in Japan (1976 in Matsuyama,^[@ref83],[@ref84]^ 1981 in Iwakuni City,^[@ref85]^ 1988 in Saga City^[@ref86]^) and the fourth in Italy.^[@ref87]^ The fifth was our reported mini-epidemic^[@ref81]^ (the close proximity of *three* patients is conventionally considered to be a mini-epidemic in the literature).^[@ref88],[@ref89]^ Clustering and epidemics thus substantiate an infectious cause.

Geographical correlation {#sec2-24}
------------------------

The early children and children in the first three epidemics were related to HBV infection. Such correlates with the high prevalence of chronic HBV infection in the 1970s-80s in Japan.^[@ref90],[@ref91]^ Geographic correlation thus supports an infectious etiology.

Subsequent laboratory evidence and universality {#sec2-25}
-----------------------------------------------

By the mid-1980s, the role of HBV infection in GCS declined,^[@ref84],[@ref93]^ to be replaced by EBV infection.^[@ref87]^ GCS was subsequently reported in association with Coxsackie viruses,^[@ref95]^ CMV,^[@ref98]^ the enteroviruses,^[@ref102]^ hepatitis A virus,^[@ref103],[@ref104]^ herpes simplex virus type 1,^[@ref105]^ HHV-6B,^[@ref106],[@ref107]^ HIV,^[@ref108],[@ref109]^ type A influenza virus,^[@ref110]^ mumps virus,^[@ref111]^ parainfluenza virus,^[@ref112]^ B19V,^[@ref113],[@ref114]^ poxviruses,^[@ref114],[@ref115]^ respiratory syncytial virus,^[@ref103]^ and rotavirus infections.^[@ref116],[@ref117]^

GCS was also associated with the following vaccines: diphtheria-pertussis-tetanus,^[@ref118]^ hepatitis A,^[@ref121]^ HBV,^[@ref124],[@ref125]^ influenza,^[@ref126]^ Japanese encephalitis,^[@ref129]^ measles,^[@ref124]^ measlesmumps-rubella,^[@ref118],[@ref130]^ and poliomyelitis (oral vaccine, US^[@ref103]^ and Turkey).^[@ref103],[@ref111]^ However, temporal relationships do not necessarily imply causal relationships.

Analyses {#sec2-26}
--------

GCS is almost universal, with most patients being young children. Concurrent patients and spatial-temporal clustering are seen. Five epidemics are reported. The epidemiological evidence strongly supports GCS being due to infection.

Asymmetric periflexural exanthem/unilateral laterothoracic exanthem {#sec1-6}
===================================================================

History: the three independent discoveries {#sec2-27}
------------------------------------------

In 1962, Brunner *et al.* reported 75 young children with a new skin rash in US.^[@ref132]^ The rash erupted unilaterally near the axilla, then extended to the trunk and the arm ([Figure 3A](#fig003){ref-type="fig"}). 30 years later, Bodemer and de Prost reported a similar rash in France which they termed *unilateral laterothoracic exanthem of childhood.*^[@ref133]^ Brunner wrote to Bodemer regarding his finding. Both agreed that these are the same or very similar rashes (Bodemer, personal communication). Taïeb *et al.* subsequently reported 21 patients with a very similar eruption in France, which they termed *unilateral laterothoracic exanthem.*^[@ref134]^ They believe that ULE is related to viral infections (Taïeb, personal communication).

These independent discoveries lend authenticity to each other, supporting APE/ULE being caused by an infectious agent.

The diagnosis of APE/ULE is clinical. Lesional histopathological changes are largely unspecific, although perisudoral lymphocytic infiltrates ([Figure 3B](#fig003){ref-type="fig"}) have been reported to be a fairly specific feature for APE/ULE/UME.

Subsequent multi-continental patient reports and laboratory evidence {#sec2-28}
--------------------------------------------------------------------

More than 300 patients with APE/ULE have been reported globally.^[@ref135]^ In most reported patients, no viral cause was identified.^[@ref135],[@ref137],[@ref138],[@ref140],[@ref147]^ Associated viruses include B19V,^[@ref141],[@ref147],[@ref154],[@ref155]^ parainfluenza virus 2,^[@ref147]^ parainfluenza 3,^[@ref147]^ and adenovirus.^[@ref142]^ However, many reports fall short of having applied sufficient investigations.^[@ref161]^

Age {#sec2-29}
---

APE/ULE mostly occurs in infancy to young childhood under four years of age,^[@ref132],[@ref140],[@ref153]^ with the youngest being four months of age.^[@ref158]^ Only 11 adults were diagnosed as having APE/ULE or its variants.^[@ref139],[@ref143],[@ref144],[@ref146],[@ref148],[@ref149],[@ref151],[@ref160]^ Two relatively young adults (aged 20 and 33 years) and one child (aged four years and nine months) have been reported to have a variant which we termed *unilateral mediothoracic exanthem* (UME).^[@ref144],[@ref149]^ Overall, the age distribution is compatible with primary viral infections.

Sex {#sec2-30}
---

The female-to-male ratio is around 2: 1.^[@ref125],[@ref127],[@ref137],[@ref148]^ The reason for this uneven distribution is unknown.

Seasonal variation {#sec2-31}
------------------

APE/ULE has a predilection to occur in the spring and summer months.^[@ref134],[@ref137],[@ref138],[@ref144],[@ref149]^ All three patients with UME occurred in early spring.^[@ref144],[@ref149]^ Such as evidence is indirect only, as non-infectious diseases might also exhibit seasonal variations.^[@ref57]^

Association with respiratory tract infections {#sec2-32}
---------------------------------------------

APE/ULS was reported to be associated with upper respiratory tract infections.^[@ref140],[@ref142]^ A viral-like prodrome also supports a viral etiology.^[@ref137],[@ref159]^

Association with immunodeficiencies {#sec2-33}
-----------------------------------

APE/ULS was reported to be associated with immunodeficiencies such as during chemotherapy for leukaemia.^[@ref141],[@ref157]^

Analyses {#sec2-34}
--------

APE/ULE is almost universally seen. The age of patients and concurrent patients support infectious etiologies. Statistically significant patient clustering has not been reported. We consider that the epidemiological evidence is adequate to substantiate an infectious etiology.

Papular-purpuric gloves and socks syndrome {#sec1-7}
==========================================

History {#sec2-35}
-------

PPGSS was first reported by Harms *et al.* for five young adults with swollen and pruritic hands and feet in 1990 in Switzerland.^[@ref162]^ The borders of affected and normal skin were distinct.^[@ref163]^ The initial papules turned purpuric one or two weeks later, followed by spontaneous remission.

Subsequent laboratory findings and multi-continental patient reports {#sec2-36}
--------------------------------------------------------------------

Three patients with PPGSS and B19V infection as substantiated by seroconversion were reported in Israel.^[@ref163]^ This association was subsequently confirmed in Saudi Arabia,^[@ref164]^ Serbia,^[@ref165]^ Greece,^[@ref166]^ Italy,^[@ref167]^ Spain,^[@ref170]^ and Switzerland.^[@ref171]^

PPGSS has then been reported to be associated with CMV,^[@ref172],[@ref173]^ Coxsackie virus B6,^[@ref174]^ EBV,^[@ref173]^ HBV,^[@ref175],[@ref176]^ HHV-6,^[@ref177]^ HIV, ^[@ref178]^ measles virus,^[@ref179]^ and rubella virus^[@ref180]^ infections. Co-infections of HHV-6 and B19V,^[@ref181]^ HHV-7 and B19V^[@ref182],[@ref183]^ were also reported in patients with PPGSS. PPGSS co-existed Henoch-Schönlein purpura in a teenager in the US.^[@ref184]^ Such multi-continental distribution supports an infectious etiology.

Age and sex {#sec2-37}
-----------

A significant proportion of patients with PPGSS are adults^[@ref171],[@ref185]^ or young adults.^[@ref191]^ Sexual preponderance is not seen. Age and sex offer little weight in sizing PPGSS as a viral exanthema.

Infectivity upon rash eruption {#sec2-38}
------------------------------

Patients with PPGSS related to B19V infection incur high infectivity by air-borne droplets. An epidemiological concern is that while *erythema infectiosum* is not infectious by the time the rash erupts, PPGSS as caused by B19V is still infectious when the rash erupts.^[@ref194]^

Concurrent patients {#sec2-39}
-------------------

Reports of concurrent patients over some support for an infectious aetiology for this exanthema.^[@ref164],[@ref186],[@ref187]^

Patient-clustering and epidemics {#sec2-40}
--------------------------------

Statistically significant patient-clustering and epidemics have not been reported for PPGSS. Such may be related to a low incidence of this exanthema.

Analyses {#sec2-41}
--------

PPGSS is almost universal. Concurrent patients are reported. However, most patients are adults or young adults, and no clustering or epidemics has been reported. The epidemiological evidence is marginally adequate for an infectious cause only.

Eruptive pseudoangiomatosis {#sec1-8}
===========================

History and universality {#sec2-42}
------------------------

EP was first described by Cherry *et al.* in 1969 in the US.^[@ref197]^ Based on its clinical course with spontaneous remission, the investigators suspected infectious etiologies. Prose *et al.* subsequently described three children with angioma-like or telangiectatic papules during viral illnesses in 1993.^[@ref198]^ The papules are blanchable, with the appearance being akin to cherry angiomas. However, lesional histopathological examinations revealed no blood vessel proliferation. This eruption was thus termed *pseudoangiomatosis.*

Subsequent multi-continental patient reports {#sec2-43}
--------------------------------------------

The initial patients with EP were believed to be caused by echovirus infection.^[@ref197]^ Subsequent laboratory findings were equivocal. A single microbiological cause has not been found.

Patients with EP were then reported in Argentina,^[@ref199]^ France, ^[@ref200]^ Greece,^[@ref205]^ Italy,^[@ref206]^ Japan,^[@ref211]^ Korea,^[@ref203],[@ref212]^ Spain, ^[@ref214],[@ref215]^ and the US.^[@ref216]^

Age and sex {#sec2-44}
-----------

EP has been reported for all ages, from neonates,^[@ref203]^ infants,^[@ref203]^ children,^[@ref197],[@ref206],[@ref208],[@ref216]^ adults,^[@ref199],[@ref204],[@ref209]^ to the elderlies.^[@ref211],[@ref213],[@ref214]^ This wide range of age argues against a single virological cause. Sexual preponderance has not be reported for EP.

Subsequent laboratory results {#sec2-45}
-----------------------------

Some patients with EP were reported to be associated with echovirus^[@ref197]^ and CMV^[@ref215]^ infections. However, most patients with EP had no infectious etiology confirmed.

Insect bites and other associating factors {#sec2-46}
------------------------------------------

EP was reported to be associated with insect bites^[@ref210],[@ref211],[@ref213]^ and with immunocompromising states, such as post-renal transplant on immunosuppressive agents,^[@ref201]^ pemphigus vulgaris on systemic corticosteroids,^[@ref205]^ and chemotherapy for Hodgkin lymphoma.^[@ref215]^ These reports suggest that EP might be the final common pathway by multiple factors which are remotely related to each other otherwise.^[@ref207]^

Other reported associations include recent hospitalization for treating malignancies or asthma.^[@ref200],[@ref203]^ The significance for these associations are yet to be established.

Seasonal variation {#sec2-47}
------------------

Seasonal variation for EP was reported in one study only, for which all seven patients developed EP during spring and summer.^[@ref214]^

Familial and concurrent patients {#sec2-48}
--------------------------------

There are reports on members in the same family with concomitant EP.^[@ref202],[@ref203],[@ref213]^

Epidemics {#sec2-49}
---------

Outbreaks of EP have been reported in France^[@ref204]^ and Italy.^[@ref209]^

Analyses {#sec2-50}
--------

EP is multi-continental, with concurrent patients and epidemics reported. However, most patients are adults, for whom no reason is found. It is associated with insert bites, immunodeficiencies, and hospitalization for the treatment of cancer or asthma. We therefore believe that the current epidemiological evidence is inadequate to substantiate or refute an infectious cause. Although the monomorphous and blanchable lesions are highly characteristic, EP might be the final common pathway for multiple unrelated origins, with subsequent very similar immunopathological, histopathological, and clinical features.

Eruptive hypomelanosis {#sec1-9}
======================

History {#sec2-51}
-------

EH is a novel paraviral exanthema.^[@ref217]^ Most reported patients are young children below the age of six. After a stage of prodromal symptoms, monomorphous hypopigmented papules of around 3-5 mm appear mainly on the extensor surfaces of the limbs ([Figure 4](#fig004){ref-type="fig"}). Systemic involvements including pharyngitis and lymphadenitis are common.^[@ref217]^

Age and sex {#sec2-52}
-----------

For the 14 patients which have been reported,^[@ref217]^ the youngest is a male child aged one year and six months. The oldest is a male aged nine years. The mean age was 4.57 years (standard deviation: 2.25 years). Ten were males and four were females. This distribution is not statistically significant (RR: 0.57; 95%CI:0.21-1.52).

Clinical evidence {#sec2-53}
-----------------

EH was suspected to be caused by a virus owing to prodromal symptoms, eruption of crops of monomorphic cutaneous lesions, concomitant systemic symptoms, and spontaneous rash remission.^[@ref217]^

Familial and concurrent patients, mini-epidemic {#sec2-54}
-----------------------------------------------

Concomitant eruption of the EH in three siblings in the same family has been reported.^[@ref220]^ This is a *mini-epidemic* according to the conventional use of the term.^[@ref88],[@ref89]^ Other clinical, laboratory, and epidemiological evidences await accumulation of more knowledge for this exanthema.

Analyses {#sec2-55}
--------

Most patients with EH are young children. We have reported a mini-epidemic which is also interfamilial. Children with EH are seen in India and in Hong Kong only in the time being. To our best knowledge, several other investigators are attempting to report children with EH. The total number of diagnosed patients is only around 20 by the time this article is being written. We therefore judge that the epidemiological data is insufficient to support an infectious etiology. It is imminent to investigate these children virologically.

Discussion {#sec1-10}
==========

As mentioned above, we lack a yardstick to judge the adequacies of epidemiology dada to support infectious etiologies, unlike virological evidences which could be more quantitative. We therefore adopted a qualitative approach, analyzing epidemiological data as reported in the literature.

However, most of such data were reported in specialist settings, which could be biased in favor of patients with more severe symptoms, more extensive rashes, longer rash durations, systemic involvements, and complications.

These exanthema are community diseases, with spontaneous remission and low risk of complications. The best proxy measure might therefore be data from primary care practices. To get such data, we might train a group of primary care clinicians to diagnose and report on these rashes. We believe that with the advancement of information technology, it is feasible to study these rashes in community as well as in specialist settings.

EH is not yet discovered and reported beyond Asia. We still incorporated such in this article owing to historical accounts of other paraviral exanthema. For PR, the first description of this exanthema was in 1860, while the herald patch was discovered in 1887, which was 27 years later.^[@ref17]^ APE/ULE was initially reported by Brunner *et al.* in 1962.^[@ref132]^ It took 30 years for Bodemer and de Prost to re-discover this rash in 1992,^[@ref133]^ and 31 years for Taïeb *et al.* to report this rash independently in 1993.^[@ref134]^

Therefore, there lies every possibility that we have reported EH now in several publications, followed by no further patients with EH reported for years and decades, then EH to be re-discovered by other investigators, as we learned from histories of discovery for other paraviral exanthema.

Limitations {#sec2-56}
-----------

A major limitation in this review is that owing to restraints in our resources, we limited our search to PubMed only. We did not search other databases such as EMBASE or LILACS for journals not indexed in PubMed, nor did we hand-search conference proceedings and unpublished reports by investigators whom we knew and who have special interests in the paraviral exanthema. We did not search the referenced lists of our retrieved articles. As most parameters are qualitative, forest plots are inapplicable for meta-analyses. Funnel plots to evaluate the extents of publication bias are also inapplicable in our analyses.

Another major limitation in our report is the lack of control conditions. For example, we could have chosen six infectious skin diseases, six non-infectious skin diseases, six infectious diseases of other body systems, and six non-infectious diseases of other body systems, and to have the epidemiology data of these diseases compared to the epidemiology data of the paraviral exanthema.

Moreover, in this article relates to the inherent nature of the epidemiological approaches. Virological properties including latent infection, endogenous reactivation, chromosomal integration (for HHV-6), multiple viral infections, and virus-virus interactions could render epidemiological methods to be futile pursuits in confirming or refuting etiologies for some or all of these exanthema.

Conclusions {#sec1-11}
===========

The current epidemiological data supports, to a moderate extent, that PR, GCS, and APE could be caused by infectious. The epidemiological evidence of PPGSS is marginally adequate to support an infectious cause. For EP, the epidemiological evidence is scattered to unrelated factors, only some of which being microbial infections. The epidemiological evidence of EH is inadequate to substantiate or to refute an infectious etiology. We hope that growing evidence in the future would further substantiate or refute the results of our analyses.

![A herald patch demonstrating peripheral collarette scaling in a patient with pityriasis rosea](idr-2016-1-6418-g001){#fig001}

![Monomorphous papules on the forearm of a patient with Gianotti-Crosti syndrome, also known as papular acrodermatitis of childhood.](idr-2016-1-6418-g002){#fig002}

![A) The rash in symmetrical periflexural exanthem, also known as unilateral laterothoracic exanthem, commences on the lateral aspect of the trunk near to the axilla. B) The presence of perisudoral lymphocytic infiltrates has been reported as a fairly specific histopathological feature in asymmetric periflexural exanthem/unilateral laterothoracic exanthem/unilateral mediothoracic exanthem (haematoxylin and eosin stain, 100x when the microphotograph was taken).](idr-2016-1-6418-g003){#fig003}

![Eruptive hypomelanosis is a recently reported paraviral exanthem with round or oval hypopigmented patch seen after a prodromal phase. The commonest sites are extensor surfaces of the limbs, as seen in this child with lesions at extensor aspects of bilateral arms.](idr-2016-1-6418-g004){#fig004}

###### 

Summary of epidemiological studies on pityriasis rosea.

  Author, year                          Location       N. patients   Male: female   Seasonal variation                                                 Incidence
  ------------------------------------- -------------- ------------- -------------- ------------------------------------------------------------------ ------------------------------------------------------------------------------
  Abercrombie, 1962^18^                 UK             138           1: 1.49        Reported no seasonal variation                                     Not reported
  Vollum, 1973^19^                      Uganda         221           1: 1.22        Reported no seasonal variation                                     2.33 per 100 dermatological patients
  Jacyk, 1980^20^                       Nigeria        138           1: 1.12        Reported no seasonal variation                                     2.42 per 100 dermatological patients
  Messenger *et al*, 1982^21^           England        126           1: 1.80        Higher incidence in winter months                                  Not reported
  Chuang *et al*, 1982^22^              USA            939           1: 1.76        Significantly higher in colder months                              172.2 per 100,000 person-years
  de Souza Sittart *et al.*, 1984^23^   Brazil         682           1: 3.01        Higher incidence in June, October and November                     0.39 per 100 dermatological patients
  Ahmed, 1986^24^                       Sudan          81            1: 1.53        Peaked in cold and dry season (January to March)                   1.09 per 100 dermatological patients
  Olumide, 1987^25^                     Lagos          152           1: 1.20        Peaked during early part of rainy season (March to July)           4.80 per 100 dermatological patients
  Cheong and Wong, 1989^27^             Singapore      214           1.85: 1        Higher incidence in March, April and November                      Not reported
  Harman *et al*, 1998^28^              Turkey         399           1: 1.21        Peaked during spring, autumn and winter                            0.75 per 100 dermatological patients
  Nanda *et al*, 1999^29^               Kuwait         117           1: 1.38        Not reported                                                       1.17 per 100 dermatological patients
  Tay and Goh, 1999^30^                 Singapore      368           1.19: 1        Reported no seasonal variation                                     0.65 per 100 dermatological patients
  Traore *et al*, 2001^31^              Burkina Faso   36            01:01          Not reported                                                       0.6 per 100 secondary school pupils (prevalence in a cross sectional survey)
  Sharma and Srivastava, 2008^33^       India          200           1.99:1         Maximum during September to December, minimum from March to June   0.25 per 100 dermatological patients
  Ayanlowo *et al*, 2010^34^            Nigeria        427           1: 1.55        Maximum in October, minimum from January to February               3.7 per 100 dermatological patients
  Ganguly, 2013^35^                     South India    73            1.35: 1        Seasonal variation not evident; few cases in the rainy season      Not reported
  Özyürek *et al*, 2014^36^             Turkey         52            1: 1.08        Maximum in February to April, minimum from July to August          Not reported

###### 

Summary of epidemiological evidence supporting infectious aetiologies in six paraviral exanthema.

                                              Universality                      Age                                                                                               Concurrent patients                  Temporal and spatial-temporal clustering                       Mini-epidemic/epidemic              Other associations
  ------------------------------------------- --------------------------------- ------------------------------------------------------------------------------------------------- ------------------------------------ -------------------------------------------------------------- ----------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Pityriasis rosea                            Yes^[@ref18]^                     Most between the ages of 10-35 years;^[@ref39],[@ref40]^ compatible with an infectious etiology   Numerous reports^[@ref45]^           Temporal clustering demonstrated^[@ref21],[@ref50],[@ref51]^   Mini-epidemics^[@ref53],[@ref55]^   Associated with primary infection or endogenous reactivations or human herpesvirus-7 and 6.^[@ref54]^ Associated with respiratory tract infections suspected;^[@ref52]^ conflicting findings for seasonal variations;^[@ref18],[@ref27],[@ref28],[@ref30],[@ref33]^ not associated with weather changes^[@ref50]^
  Gianotti-Crosti syndrome                    Yes^[@ref72],[@ref95],[@ref96]^   Most below three to four years of age^[@ref77],[@ref78]^                                          Yes^[@ref72]^                        Spatial-temporal clustering demonstrated^[@ref83]^             Yes^[@ref84]^                       Associated with hepatitis B virus.^[@ref84]^ Epstein Barrvirus,^[@ref71]^ Coxsackie viruses,^[@ref96]^ cytomegalovirus,^[@ref97],[@ref99]^ enteroviruses,^[@ref103]^ hepatitis Avirus,^[@ref104],[@ref105]^ herpes simplex virus type 1,^[@ref106]^ human herpesvirus 6,^[@ref100],[@ref107]^ HIV,^[@ref108],[@ref109]^ influenza virus,^[@ref110]^ mumps virus,^[@ref111]^ parainfluenza virus,^[@ref112]^ parvovirus B19,^[@ref113],[@ref114]^ poxviruses,^[@ref114],[@ref115]^ respiratory syncytial virus,^[@ref103]^ and rotavirus^[@ref116],[@ref117]^ infections
  Asymmetric periflexural exanthem            Yes^[@ref135]^                    Most in infancy to young childhood^[@ref132],[@ref139],[@ref145],[@ref151]^                       Yes^[@ref137],[@ref138]^             \-                                                             \-                                  Associated with respiratory tract infections,^[@ref140],[@ref142]^ and immunodeficiencies,^[@ref140],[@ref157]^ parvovirus B19,^[@ref141],[@ref147],[@ref154],[@ref155]^ parainfluenza virus types 2,^[@ref147]^ and 3,^[@ref147]^ adenovirus^[@ref142]^ virus infections. Predilection to occur in spring and summer months.^[@ref134],[@ref137],[@ref138],[@ref147]^
  Papular-purpuric gloves and sock syndrome   Yes^[@ref163]^                    Mostly adults^[@ref71],[@ref184]^ and young adults^[@ref190]^                                     Yes^[@ref164],[@ref195],[@ref196]^   \-                                                             \-                                  \-
  Eruptive pseudoangiomatosis                 Yes^[@ref197]^                    All ages, mostly a dults^[@ref200],[@ref204],[@ref205],[@ref209]^                                 Yes^[@ref202],[@ref203],[@ref213]^   \-                                                             Yes^[@ref204],[@ref209]^            Associated with insect bites,^[@ref210],[@ref211],[@ref213]^ immunodeficiency^[@ref201],[@ref205],[@ref215]^ and hospitalization for treating malignancies or asthma^[@ref200],[@ref203]^
  Eruptive hypomelanosis                      \-                                Mostly children below the age of six years^[@ref217]^                                             Yes^[@ref220]^                       \-                                                             Yes^[@ref220]^                      \-

[^1]: Contributions: AC, original conceptualization of the systematic review, devising the methodology, data collection, data interpretation, drafting the first version, writing the final version; VZ, systematic literature search, data interpretation, inputs on clinical aspects, drafting the first version, writing the final version, as corresponding author liaising with co-authors and the journal; GS, drafting the first version, data interpretation, responsible to respond to reviewers' comments, checking the English language, finalizing the article for submission; WK, data interpretation, inputs in virological aspects, drafting the first version, critical review, finalizing the article for submission; AL, data interpretation, inputs in epidemiological aspects, drafting the first version, critical review, finalizing the article for submission.

[^2]: Conflict of interest: the authors declare no potential conflict of interest.
